{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:27:27Z","timestamp":1790386047522,"version":"4.1.0"},"reference-count":27,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2020,9,29]]},"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:sec id=\"s1\">\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Psoriatic arthritis (PsA) is a heterogeneous chronic inflammatory musculoskeletal disorder that manifests as peripheral arthritis, dactylitis, enthesitis and spondylitis. PsA results in significant burden that impacts quality of life of patients. We examined the signs, symptoms and impacts reported by patients with PsA, to characterise the patient experience of PsA and develop a conceptual model representing this patient experience.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"s2\">\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Semi-structured interviews were conducted with patients with PsA recruited through the FORWARD databank. Spontaneous and probed signs, symptoms and impacts of PsA were assessed. Patients rated the disturbance of these concepts on their lives using a scale from 0 (\u2018does not disturb\u2019) to 10 (\u2018greatly disturbs\u2019). Signs, symptoms and impacts reported by &gt;80% of patients with a disturbance rating of \u22655 were defined as salient concepts. Recruitment continued until concept saturation was achieved.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"s3\">\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>19 patients with PsA were interviewed. The interviews elicited 42 symptoms of which 8 had not been identified in a previous literature review encompassing 15 relevant articles. The most salient signs and symptoms elicited in the interviews were joint pain, skin symptoms, stiffness, swollen\/inflamed joints and fatigue all with moderate to high disturbance ratings (range: 5.5\u20137.8). The most salient impacts were sleep disturbance, physical disability, effects on daily activities and feelings of frustration with also moderate to high disturbance ratings (range: 6.1\u20137.4).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"s4\">\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The interviews highlighted the adverse impact PsA has on the patient\u2019s life and may inform on outcome variables or areas suitable to be assessed in PsA studies.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/rmdopen-2020-001321","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T18:16:04Z","timestamp":1603908964000},"page":"e001321","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":39,"title":["Patient\u2019s experience of psoriatic arthritis: a conceptual model based on qualitative interviews"],"prefix":"10.1136","volume":"6","author":[{"given":"Alexis","family":"Ogdie","sequence":"first","affiliation":[{"name":"University of Pennsylvania, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5350-3934","authenticated-orcid":false,"given":"Kaleb","family":"Michaud","sequence":"additional","affiliation":[{"name":"National Data Bank for Rheumatic Diseases, Wichita, Kansas, USA"},{"name":"University of Nebraska Medical Center, Omaha, Nebraska, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslawa","family":"Nowak","sequence":"additional","affiliation":[{"name":"BMS, Princeton, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Bruce","sequence":"additional","affiliation":[{"name":"IQVIA, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cantor","sequence":"additional","affiliation":[{"name":"IQVIA, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlijn","family":"Hintzen","sequence":"additional","affiliation":[{"name":"IQVIA Europe, Amsterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6620-0457","authenticated-orcid":false,"given":"Philip J","family":"Mease","sequence":"additional","affiliation":[{"name":"School of Medicine, Swedish Medical Center and University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,10,28]]},"reference":[{"key":"2025090312530893000_6.3.e001321.1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s40265-014-0191-y","article-title":"Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis","volume":"74","author":"Mease","year":"2014","journal-title":"Drugs"},{"key":"2025090312530893000_6.3.e001321.2","first-page":"680","article-title":"The burden of psoriatic arthritis: a literature review from a global health systems perspective","volume":"35","author":"Lee","year":"2010","journal-title":"P T"},{"key":"2025090312530893000_6.3.e001321.3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/1744666X.2018.1468252","article-title":"Quality of life in psoriatic arthritis","volume":"14","author":"Gudu","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"2025090312530893000_6.3.e001321.4","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.032482"},{"key":"2025090312530893000_6.3.e001321.5","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/rheumatology\/ker365","article-title":"Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone","volume":"51","author":"Rosen","year":"2011","journal-title":"Rheumatology"},{"key":"2025090312530893000_6.3.e001321.6","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210242"},{"key":"2025090312530893000_6.3.e001321.7","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq155"},{"key":"2025090312530893000_6.3.e001321.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2011.06.014"},{"key":"2025090312530893000_6.3.e001321.9","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205207"},{"key":"2025090312530893000_6.3.e001321.10","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100179"},{"key":"2025090312530893000_6.3.e001321.11","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev009"},{"key":"2025090312530893000_6.3.e001321.12","doi-asserted-by":"publisher","DOI":"10.1002\/art.22605"},{"key":"2025090312530893000_6.3.e001321.13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40744-016-0029-z","article-title":"Psoriatic arthritis and burden of disease: patient perspectives from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) survey","volume":"3","author":"Kavanaugh","year":"2016","journal-title":"Rheumatol Ther"},{"key":"2025090312530893000_6.3.e001321.14","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170500"},{"key":"2025090312530893000_6.3.e001321.15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s40271-017-0221-4","article-title":"Important treatment outcomes for patients with psoriatic arthritis: a multisite qualitative study","volume":"10","author":"Dures","year":"2017","journal-title":"Patient"},{"key":"2025090312530893000_6.3.e001321.16","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/34.12.1167"},{"key":"2025090312530893000_6.3.e001321.17","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/acr.22256","article-title":"Effect of certolizumab pegol on multiple facets of psoriatic arthritis as reported by patients: 24-week patient-reported outcome results of a phase III, multicenter study","volume":"66","author":"Gladman","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025090312530893000_6.3.e001321.18","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-209055"},{"key":"2025090312530893000_6.3.e001321.19","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.121200"},{"key":"2025090312530893000_6.3.e001321.20","doi-asserted-by":"publisher","DOI":"10.1080\/13814788.2017.1375091"},{"key":"2025090312530893000_6.3.e001321.21","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/BOR.0000000000000388","article-title":"Fibromyalgia, a missed comorbidity in spondyloarthritis: prevalence and impact on assessment and treatment","volume":"29","author":"Mease","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"2025090312530893000_6.3.e001321.22","first-page":"1900","article-title":"Seasonal symptom severity in patients with rheumatic diseases: a study of 1,424 patients","volume":"28","author":"Hawley","year":"2001","journal-title":"J Rheumatol"},{"key":"2025090312530893000_6.3.e001321.23","first-page":"226","article-title":"Weather conditions may worsen symptoms in rheumatoid arthritis patients: the possible effect of temperature","volume":"9","author":"Abasolo","year":"2013","journal-title":"Rheumatol Clin"},{"key":"2025090312530893000_6.3.e001321.24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12891-016-0911-4","article-title":"Seasonal variations in fatigue in persons with rheumatoid arthritis: a longitudinal study","volume":"17","author":"Feldthusen","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"2025090312530893000_6.3.e001321.25","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-201208"},{"key":"2025090312530893000_6.3.e001321.26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41927-018-0049-0","article-title":"Living life precariously with rheumatoid arthritis - a mega-ethnography of nine qualitative evidence syntheses","volume":"3","author":"Toye","year":"2019","journal-title":"BMC Rheumatol"},{"key":"2025090312530893000_6.3.e001321.27","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/rheumatology\/keq282","article-title":"Fatigue in rheumatoid arthritis: time for a conceptual model","volume":"50","author":"Hewlett","year":"2010","journal-title":"Rheumatology"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2020-001321","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T19:53:24Z","timestamp":1756929204000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2020-001321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,10,28]]},"published-print":{"date-parts":[[2020,10]]}},"alternative-id":["10.1136\/rmdopen-2020-001321"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2020-001321","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10]]}}}